-
1
-
2
-
3
Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Retrospective analysis of clinical results and predictors of response in chemo-na ve patients with advanced gastric cancer treated with S-1, an oral fluoropyrimidine derivative, as...
Veröffentlicht in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
VolltextArtikel